Vitiligo results from the loss of melanocytes, the cells responsible for producing skin pigment. The exact cause isn’t a single factor but a combination of genetic susceptibility, immune system malfunction, oxidative damage, and environmental triggers that work together to destroy these pigment-producing cells. It affects roughly 0.5% to 1% of the global population, occurs equally in males and females, and most commonly appears in adulthood.
Autoimmune Attack on Pigment Cells
The leading explanation for vitiligo centers on the immune system. In most cases, the body’s own T cells (a type of white blood cell designed to fight infections) mistakenly identify melanocytes as threats and destroy them. This is why vitiligo is classified as an autoimmune condition, and why it so often appears alongside other autoimmune diseases.
About 15.7% of people with vitiligo also have thyroid disease, making it the most common overlapping condition. Alopecia areata, the autoimmune form of hair loss, is the second most common, affecting roughly 3.8% of vitiligo patients. These overlapping conditions share many of the same genetic risk factors, which points to a broader pattern of immune dysregulation rather than a problem specific to the skin alone.
Genetics Load the Gun
Vitiligo runs in families, though not in a straightforward way. No single gene causes the condition. Instead, researchers have identified over 50 genes that each contribute a small amount of risk. These fall into two broad categories: genes that regulate the immune system and genes that affect melanocyte biology.
On the immune side, many of the risk genes control how T cells activate, how B cells communicate, and how the body regulates inflammation. One well-studied example, PTPN22, influences how T cells respond to signals, and variants in this gene are also linked to type 1 diabetes and rheumatoid arthritis. Other immune-related risk genes govern regulatory T cells, the subset that normally prevents the immune system from attacking the body’s own tissues. When these regulatory mechanisms are weakened by genetic variation, the brake system on autoimmune responses becomes less effective.
On the melanocyte side, genes like TYR (which controls the key enzyme in melanin production) and MC1R (the receptor for melanocyte-stimulating hormone) are also risk factors. This is a critical insight: the very genes that make melanocytes function normally also make them visible targets for immune attack. In a sense, the pigment-production machinery itself may generate molecules that the immune system learns to recognize and destroy.
Oxidative Stress Weakens Melanocytes
Melanocytes in people with vitiligo appear to be unusually sensitive to oxidative stress, the cellular damage caused by a buildup of reactive oxygen molecules like hydrogen peroxide. Every cell produces these molecules as a byproduct of normal metabolism, but healthy cells neutralize them with antioxidant defense systems.
In vitiligo, this defense system is impaired. Research has shown that melanocytes from vitiligo patients have a defective antioxidant signaling pathway. Specifically, the system that activates protective antioxidant enzymes doesn’t work as well as it should. The result is that hydrogen peroxide and other damaging molecules accumulate inside melanocytes, injuring them from within. This internal damage can both kill melanocytes directly and make them release stress signals that attract immune cells, creating a vicious cycle where oxidative injury triggers autoimmune destruction.
Physical Trauma and Chemical Exposure
Many people with vitiligo notice that new white patches appear at sites of skin injury. This is called the Koebner phenomenon, and it’s one of the most recognizable triggers for the condition. Any injury that penetrates both the outer and middle layers of skin can set it off: cuts, burns, surgical wounds, tattoos, piercings, insect bites, and even severe sunburns. Friction from tight clothing or repetitive rubbing can also trigger depigmentation in susceptible individuals.
The mechanism behind this involves how melanocytes attach to surrounding tissue. In people with vitiligo, the adhesion molecules that anchor melanocytes to the base of the skin are often defective. When the skin experiences mechanical stress like friction or trauma, melanocytes can physically detach from their normal position and migrate toward the skin’s surface, where they eventually die. This process has been observed even in skin that appears normal but borders existing vitiligo patches. Studies of unstable vitiligo have found that melanocytes are poorly attached to the structural proteins around them and show elevated markers of cell death, while melanocytes in stable vitiligo adhere firmly.
Chemical exposure is another well-documented trigger. Phenol-based compounds, found in some industrial chemicals, hair dyes, rubber products, and adhesives, can directly damage melanocytes. Workers in manufacturing settings who handle these chemicals sometimes develop vitiligo-like depigmentation on their hands and arms first.
Nerve Signaling and Segmental Vitiligo
A subset of vitiligo, called segmental vitiligo, follows a distinct pattern. Rather than appearing symmetrically on both sides of the body, it affects only one area, often matching the distribution of a specific nerve. This pattern has led researchers to investigate whether nerve endings themselves play a role in triggering pigment loss.
The evidence points to neuropeptides, chemical messengers released by nerve endings in the skin. One called neuropeptide Y (NPY) has been found at significantly higher levels in both segmental and localized vitiligo compared to healthy skin, with the highest levels appearing during the active, spreading phase of the disease. These neuropeptides can damage melanocytes directly and also trigger local immune and inflammatory responses that lead to further melanocyte destruction.
This nerve-mediated pathway helps explain why emotional stress is so commonly reported as a trigger for vitiligo flares. Stress activates the nervous system in ways that increase neuropeptide release in the skin, potentially initiating or accelerating pigment loss in people who are already genetically predisposed.
How These Causes Work Together
No single cause fully explains vitiligo. The current understanding is a convergence model: genetic susceptibility creates the foundation, oxidative stress weakens melanocytes and makes them more vulnerable, environmental triggers like skin injury or chemical exposure provide the spark, and the immune system delivers the final blow by targeting damaged melanocytes for destruction. In segmental cases, nerve signaling adds another layer.
This is why vitiligo can be so unpredictable. Two people with the same genetic risk may have very different outcomes depending on their environmental exposures, stress levels, and whether they experience skin trauma. It also explains why the condition can remain stable for years and then suddenly spread: a new trigger re-activates the cycle in skin that was previously unaffected but always carried the underlying vulnerability.